As Galille13, Tiglah and Shin3 have pointed out, it could be anything... possibly positive.
Some co's issued AR followed by a 'Strategiy Update", others include S/Update in the ARs.
Tiglah has given us a few examples of 'waiting till the last mile' ,where the gold and rainbow is - A2M , $6 mining stock .
Here is another real story - Xero
When it was first IPOed in NZX at $1 (A0.80), i mentioned to MrsG, and she said 'Its too risky. Startup '.
Sp fluctuated $1 to 60c for 2-3 years, until former MYOB founder sold his myob stake and put most of the sale proceeds into Xero, at 80c (?)
Mkt began to take notice.
Sp climbed from NZ$1,2,3,4,$5.
MrsG still said, "It too risky. Too many unknowns"
I bought some at A$5, when it was dual-listed in ASX, then only i told MrsG who protested 'its too risky". (Too late, bought it..., haha).
She was getting nervous when sp hit A$10,15,20, 25,A$30 ( within a year?) and urged me to sell out for each $5 increment. I relented at $30.
(It was one of the best investment in years - among other successes n flops)
Sp did yoyo from A$30,40,13, but for other LTHs, its now A$44:
$1 to $44.
Not bad at all.
I am sure along Xero long journey shhs experienced emotional setbacks, NSX and ASX queries, THs, VSs, speeding tickets etc
Will GMV under Yacov do another A2m or Xero?
I don't know.
We will find out in a few months or next 1-2 years.
Lets stay positive and optimistic...its free of charge. So is anxiety.
IF Gmv hit the jackpots for Yacov and all LTHs here, it will more than compensate for some 'fleas we may have carried in last 12 months.
aimo.dyor.
Apology to you and others if i previous posts upset anyone.
- Forums
- ASX - By Stock
- GMV
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-77
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online